Research Paper Volume 16, Issue 10 pp 8944—8964
SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer
Figure 3. The survival curve of SLAMF8 in pan-cancer using Kaplan-Meier analysis and log-rank test. P-values < 0.05 were considered and shown. (A) The survival curve of SLAMF8 for OS in 10 kinds of tumor. (B) The survival curve of SLAMF8 for DFI in 3 kinds of tumor. (C) The survival curve of SLAMF8 for DSS in 8 kinds of tumor. (D) The survival curve of SLAMF8 for PFI in 9 kinds of tumor.